Clinical Trial Update: A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating the efficacy and safety of HRS-1301 for hyperlipidemia is currently recruiting. Sponsor: Shandong Suncadia Medicine Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• HRS-1301

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Hyperlipidemia | Phase 2 | Status: RECRUITING